Preclinical Evaluation of the Immunogenicity and Safety of an Inactivated Enterovirus 71 Candidate Vaccine

Open Access

Peer-reviewed

Research Article

Shi-Hsia Hwa ,

* E-mail: hwashihsia@gmail.com

Affiliation Inviragen (Singapore) Pte. Ltd., Singapore, Singapore
⨯
Yock Ann Lee,

Affiliation Inviragen (Singapore) Pte. Ltd., Singapore, Singapore
⨯
Joseph N. Brewoo,

Affiliation Inviragen Inc., Madison, Wisconsin, United States of America
⨯
Charalambos D. Partidos,

Affiliation Inviragen Inc., Madison, Wisconsin, United States of America
⨯
Jorge E. Osorio,

Affiliations Inviragen Inc., Madison, Wisconsin, United States of America, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Madison, Wisconsin, United States of America
⨯
Joseph D. Santangelo

Affiliation Inviragen (Singapore) Pte. Ltd., Singapore, Singapore
⨯

Reader Comments (0)

Antigens
Is the Subject Area "Antigens" applicable to this article?

Thanks for your feedback.
Viral vaccines
Is the Subject Area "Viral vaccines" applicable to this article?

Thanks for your feedback.
Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Booster doses
Is the Subject Area "Booster doses" applicable to this article?

Thanks for your feedback.
Hand, foot and mouth disease
Is the Subject Area "Hand, foot and mouth disease" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Immunologic adjuvants
Is the Subject Area "Immunologic adjuvants" applicable to this article?

Thanks for your feedback.